Tumor metrics imaging core labs: primer for radiologists.

Rachana Gurudu¹, Dhruv Bansal², Anil Chauhan³, Sree Harsha Tirumani^4,5

¹Case Western Reserve University, Cleveland, USA.

²Department of Medical Oncology, Endeavor Health, Chicago, USA.

³Department of Radiology, University of Kansas Medical Center, Kansas City, USA.

⁴Department of Radiology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, USA. sreeharsha.tirumani@uhhospitals.org.

⁵Case Western Reserve University, Cleveland, USA. sreeharsha.tirumani@uhhospitals.org.

PubMed DOI

Abstract

Imaging biomarkers have emerged as increasingly important endpoints in cancer clinical trials. Incorporating tumor metric reads as part of routine clinical reads by on-site radiologists for cancer clinical trials has several challenges which can be addressed by tumor metrics imaging core lab. Despite the operational and financial challenges inherent in establishing and maintaining tumor metrics im…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.